Home > Balance Sheet > AUROBINDO PHARMA

AUROBINDO PHARMA
Sundry Debtors

    Back to Balance Sheet
AUROBINDO PHARMA is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Sundry Debtors History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Sundry Debtors ₹7,094 Cr₹5,746 Cr₹4,817 Cr₹4,466 Cr₹4,012 Cr

What is the latest Sundry Debtors ratio of AUROBINDO PHARMA ?

The latest Sundry Debtors ratio of AUROBINDO PHARMA is ₹7,094 Cr based on Mar2026 Consolidated results.
Year Sundry Debtors
Mar2026₹7,094 Cr
Mar2025₹5,746 Cr
Mar2024₹4,817 Cr
Mar2023₹4,466 Cr
Mar2022₹4,012 Cr

How is Sundry Debtors of AUROBINDO PHARMA Trending?

Years Sundry Debtors % Change
Mar2026 ₹7,094 Cr
23.47
Mar2025 ₹5,746 Cr
19.29
Mar2024 ₹4,817 Cr
7.84
Mar2023 ₹4,466 Cr
11.32
Mar2022 ₹4,012 Cr -

Compare Sundry Debtors of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹99,256.5 Cr 2.4% 7.2% 54.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹447,476.0 Cr -0.1% -2.4% 13.8% Stock Analytics
DIVIS LABORATORIES ₹254,764.0 Cr 2.7% 12.9% 54.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,423.0 Cr 1.8% 2.5% 40.9% Stock Analytics
CIPLA ₹111,484.0 Cr 0.6% -3.8% -11.4% Stock Analytics
DR REDDYS LABORATORIES ₹101,005.0 Cr 3.3% 1.3% -7.6% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

2.4%

7.2%

54.8%

SENSEX

0.7%

-3.5%

-9.2%


You may also like the below Video Courses